FindTrial
Sign In

Association between intercellular adhesion molecule 1 (ICAM1) polymorphisms and diabetic foot susceptibility: a case-control study

Association between intercellular adhesion molecule 1 (ICAM1) polymorphisms and diabetic foot susceptibility: a case-control study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025172
Enrollment
Unknown
Registered
2019-08-15
Start date
2017-04-01
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic foot

Interventions

DF group:PCR-RFLP
T2DM:PCR-RFLP
control:PCR-RFLP

Sponsors

Xuanwu Hospital of Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
38 Years to 76 Years

Inclusion criteria

Inclusion criteria: 128 T2DM patients with DF were selected as case group (DF group), 147 T2DM patients without any complications were recruited as T2DM group. Besides, 155 healthy persons with normal glucose tolerance and conducting regular healthy checkup were randomly enrolled as control group.

Exclusion criteria

Exclusion criteria: individuals had severe systemic diseases, vascular diseases, neurogenic diseases or tumors.

Design outcomes

Primary

MeasureTime frame
rs5498;rs3093030 genotype;—

Countries

China

Contacts

Public ContactXue-xia Cao

Xuanwu Hospital of Capital Medical University

shuoxoa@163.com+86 010-83198170

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026